Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval
June 07, 2021 at 20:21 PM EDT
"Desperation should drive funding for Alzheimer's research, it should not drive the interpretation of scientific evidence," Karlawish said.